On October 29, UiPath fell 5.21% in Pre-Market Trading, with shares trading at $13.51 and turnover of $271.3 thousand.
The clearest recent catalyst in the available information is BofA’s October 23 target cut to $12 from $15 while maintaining an Underperform rating, alongside commentary that UiPath faces elevated downward estimate revision risk in enterprise AI software.
That call added to a string of cautious analyst actions after UiPath’s September-quarter reporting cycle. In late September, DA Davidson downgraded the stock to Underperform and cut its target to $10 from $16, while UBS, Truist, RBC, and others also trimmed or tempered views. Although UiPath previously reported fiscal Q2 revenue of $410.3 million, above expectations, and raised full-year revenue guidance to $1.789 billion-$1.794 billion, analysts continued to focus on limited evidence of sustained growth re-acceleration and a still unproven transition toward broader business orchestration and AI monetization.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments